Biotivia has signed an agreement to collaborate with Dr. Roberto Gambari, head of the Thal Lab at the University of Ferrara, to test the ability of Transmax to induce fetal hemaglobin cells in Thalasemmia patients. In vitro studies have shown a remarkable ability of Transmax to induce new red blood cells in the blood of human patients. This is highly significant as the alternative these sufferers have is a lifetime of whole blood transfusions and costly highly toxic pharmaceuticals.
Biotivia Blog
- Recent Articles
- Chilli compound may boost energy burning and help weight loss
- Juice concentrates show anti-inflammatory potential
- Red Wine Ingredient Increases Insulin Sensitivity, Works Against Retinal Disease
- Green Tea Extract Appears to Keep Cancer in Check in Majority of CLL Patients
- Chronic colitis patients could benefit from resveratrol, says Spanish study
- Spend on science not marketing for a positive health claim: EFSA scientist
- Red Wine Ingredient Increases Insulin Sensitivity, Works Against Retinal Disease
- Biotivia Launch Innovative Prebiotic Health Supplement
- Probiotics Improve Atopic Dermatitis
- First human trial backs GS diabetes benefits
Biotivia signs agreement to do human trials
3 Comments »
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.
1-800-458-0993 (8am - 5pm CST)
1-888-245-5893
Simply amazing. Once again Biotivia is one step beyond.
Comment by THEHUGE — December 12, 2009 @ 7:56 am
What can I say….Biotivia is the absolute leader in research and development.
Comment by THEHUGE — December 12, 2009 @ 8:02 am
That’s nice product.Biotivia is really affective .i like it. thanks.
South Beach Brite
Comment by trescothick — December 14, 2009 @ 3:18 am